Financhill
Sell
45

UNH Quote, Financials, Valuation and Earnings

Last price:
$531.95
Seasonality move :
9.57%
Day range:
$509.51 - $524.67
52-week range:
$436.38 - $630.73
Dividend yield:
1.56%
P/E ratio:
34.17x
P/S ratio:
1.25x
P/B ratio:
5.11x
Volume:
4.1M
Avg. volume:
5.8M
1-year change:
-2.24%
Market cap:
$482.7B
Revenue:
$367.5B
EPS (TTM):
$15.35

Analysts' Opinion

  • Consensus Rating
    UnitedHealth Group has received a consensus rating of Buy. The company's average rating is a Buy based on 18 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $636.78, UnitedHealth Group has an estimated upside of 21.4% from its current price of $524.52.
  • Price Target Downside
    According to analysts, the lowest downside price target is $587.12 representing -11.94% downside risk from its current price of $524.52.

Fair Value

  • According to the consensus of 21 analysts, UnitedHealth Group has 21.4% upside to fair value with a price target of $636.78 per share.

UNH vs. S&P 500

  • Over the past 5 trading days, UnitedHealth Group has overperformed the S&P 500 by 4.11% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • UnitedHealth Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • UnitedHealth Group has grown year-over-year revenues for 140 quarters straight. In the most recent quarter UnitedHealth Group reported revenues of $99.2B.

Earnings Growth

  • UnitedHealth Group has grown year-over-year earnings for 1 quarter straight. In the most recent quarter UnitedHealth Group reported earnings per share of $6.51.
Enterprise value:
533.5B
EV / Invested capital:
--
Price / LTM sales:
1.25x
EV / EBIT:
22.35x
EV / Revenue:
1.37x
PEG ratio (5yr expected):
--
EV / Free cash flow:
40.74x
Price / Operating cash flow:
37.17x
Enterprise value / EBITDA:
19.12x
Gross Profit (TTM):
$85.3B
Return On Assets:
5.02%
Net Income Margin (TTM):
3.68%
Return On Equity:
14.51%
Return On Invested Capital:
8.46%
Operating Margin:
7.12%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $313.1B $356.2B $389.1B $91.4B $99.2B
Gross Profit $74.3B $86.1B $85.3B $22.4B $21.4B
Operating Income $25.1B $27.8B $27.4B $7.5B $7.1B
EBITDA $30.3B $35.5B $27.9B $9.5B $9.7B
Diluted EPS $20.42 $23.04 $15.35 $6.24 $6.51
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $54.8B $61.6B $82.9B $91.9B $92.3B
Total Assets $191B $213B $243.1B $282.1B $299.3B
Current Liabilities $66.6B $79.6B $100.9B $114.2B $101.6B
Total Liabilities $121B $138.4B $160.1B $188.1B $194.9B
Total Equity $70B $74.6B $82.9B $94B $104.5B
Total Debt $43.8B $47B $48.7B $63.4B $78B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations $34B $29.7B $16.6B $6.9B $13.9B
Cash From Investing -$12.4B -$29.8B -$20.6B -$2.6B -$5.7B
Cash From Financing -$3.8B $19M -$2.3B -$7.1B -$2.2B
Free Cash Flow $31.3B $26.4B $13.1B $6.1B $13B
UNH
Sector
Market Cap
$482.7B
$47.1M
Price % of 52-Week High
83.16%
48%
Dividend Yield
1.56%
0%
Shareholder Yield
1.57%
-0.74%
1-Year Price Total Return
-2.24%
-33.14%
Beta (5-Year)
0.617
0.754
Dividend yield:
1.56%
Annualized payout:
$7.29
Payout ratio:
51.26%
Growth streak:
14 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $511.70
200-day SMA
Sell
Level $539.50
Bollinger Bands (100)
Sell
Level 537.12 - 604.82
Chaikin Money Flow
Buy
Level 329.9M
20-day SMA
Buy
Level $511.26
Relative Strength Index (RSI14)
Sell
Level 47.85
ADX Line
Buy
Level 32.26
Williams %R
Sell
Level -0.3879
50-day SMA
Sell
Level $558.44
MACD (12, 26)
Sell
Level -13.16
25-day Aroon Oscillator
Sell
Level -36
On Balance Volume
Neutral
Level 531.8M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.8021)
Buy
CA Score (Annual)
Level (-0.171)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-1.1751)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 50 million members globally, including 1 million outside the us as June 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Stock Forecast FAQ

In the current month, UNH has received 18 Buy ratings 3 Hold ratings, and 0 Sell ratings. The UNH average analyst price target in the past 3 months is $636.78.

  • Where Will UnitedHealth Group Stock Be In 1 Year?

    According to analysts, the consensus estimate is that UnitedHealth Group share price will rise to $636.78 per share over the next 12 months.

  • What Do Analysts Say About UnitedHealth Group?

    Analysts are divided on their view about UnitedHealth Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that UnitedHealth Group is a Sell and believe this share price will drop from its current level to $587.12.

  • What Is UnitedHealth Group's Price Target?

    The price target for UnitedHealth Group over the next 1-year time period is forecast to be $636.78 according to 21 Wall Street analysts, 18 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.

  • Is UNH A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for UnitedHealth Group is a Buy. 18 of 21 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of UNH?

    You can purchase shares of UnitedHealth Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase UnitedHealth Group shares.

  • What Is The UnitedHealth Group Share Price Today?

    UnitedHealth Group was last trading at $531.95 per share. This represents the most recent stock quote for UnitedHealth Group. Yesterday, UnitedHealth Group closed at $524.52 per share.

  • How To Buy UnitedHealth Group Stock Online?

    In order to purchase UnitedHealth Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is ARK Next Generation Internet ETF a Good Investment?
Is ARK Next Generation Internet ETF a Good Investment?

The ARK Next Generation Internet ETF looks like a pretty…

Why Is Marvell Stock Up?
Why Is Marvell Stock Up?

Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…

Why Is General Electric Stock Going Up?
Why Is General Electric Stock Going Up?

General Electric Company, doing business these days as GE Aerospace…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
44
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
1
IONQ alert for Jan 10

IonQ [IONQ] is up 8.17% over the past day.

Sell
40
QMCO alert for Jan 10

Quantum [QMCO] is down 7.45% over the past day.

Sell
47
MATW alert for Jan 10

Matthews International [MATW] is down 5.61% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock